Wendy Bongers, MD
Family Medicine · Woodbury, MNNPI 1306803135
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $291 and has fallen 55.6% since, to $129 in 2024. Among family medicine clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$140
- Optinose US, Inc.$125
- Lilly USA, LLC$110
- Johnson & Johnson$99
- Incyte Corporation$83
- Sanofi$64
- plus $355 from 12 others
What the payments were for
- Food & beverage$96298%
- Education$152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $140 |
| Optinose US, Inc. | 2 | $125 |
| Lilly USA, LLC | 8 | $110 |
| Johnson & Johnson | 6 | $99 |
| Incyte Corporation | 5 | $83 |
| Sanofi | 4 | $64 |
| Sun Pharmaceutical Industries Inc. | 4 | $63 |
| Galderma Laboratories, L.p. | 3 | $42 |
| Amgen | 3 | $41 |
| UCB, Inc. | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $30 |
| VYNE Pharmaceuticals Inc. | 1 | $29 |
| LEO Pharma Inc. | 2 | $29 |
| Pfizer | 2 | $23 |
| Bristol Myers Squibb | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| AbbVie | 1 | $13 |
| Strata Skin Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$114
How this compares
$977 in reported general payments places this provider in the 90th percentile of 1,162 family medicine providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 214 | $5,066 |
| Metronidazole | 63 | $3,976 |
| Fluorouracil | 31 | $2,698 |
| Clindamycin Phosphate | 34 | $1,346 |
| Doxycycline Monohydrate | 42 | $1,304 |
| Fluocinolone Acetonide | 19 | $1,091 |
| Fluocinonide | 22 | $1,086 |
| Clobetasol Propionate | 28 | $946 |
| Triamcinolone Acetonide | 61 | $795 |
| Hydrocortisone | 57 | $406 |
| Doxycycline Hyclate | 21 | $398 |
| Mupirocin | 13 | $94 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Woodbury
- Henrik SlotsWoodbury$5K
- Amanda LovoldSt Cloud$387K
- Robert MarshMinnetonka$300K
- Taylor MertzMoorhead$176K
- Justin YoungTracy$93K
- Gerard SpoelhofDuluth$75K
- Martha MasciopintoCottage Grove$50K
- Glenn DetlefsenRosemount$39K
- Amy GilbertSaint Paul$27K
- Kevin PetersonMinneapolis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.